Article
Single cell multiomics reveals drivers of metabolic dysfunction-associated steatohepatitis
2025-05-11
Abstract excerpt
Metabolic dysfunction-associated steatotic liver disease (MASLD) has limited treatments, and cell type-specific regulatory networks driving MASLD represent therapeutic avenues. We assayed five transcriptomic and epigenomic modalities in 2.4M cells from 86 livers across MASLD stages. Integrating modalities increased annotation of the genome in liver cell types several-fold over previous catalogs. We identified cell...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4fcef3c1-e50d-5154-8c9d-e71cc9531265
- DOI
- 10.1101/2025.05.09.25327043
